Table 3.
Not adjusted | With adjustmenta | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | p | |
BMQ-subscales | ||||||
General beliefs | ||||||
Overuse | 0.70 | 0.47–1.06 | .09 | 0.61 | 0.37–1.00 | .05 |
Harm | 0.81 | 0.52–1.25 | .34 | 0.87 | 0.53–1.42 | .58 |
Utility | 1.29 | 0.84–1.98 | .25 | 1.40 | 0.85–2.30 | 0.18 |
Specific beliefs | ||||||
Necessity | 1.56 | 1.00–2.44 | .05 | 2.46 | 1.36–4.42 | <.01 |
Concerns | 0.64 | 0.43–0.97 | .03 | 0.86 | 0.53–1.41 | .55 |
OR odds ratio, 95% CI 95% confidence interval, BMQ Beliefs about Medicines-Questionnaire, MARS Medication Adherence Report-Scale
aModels adjusted for inpatient/outpatient treatment, CAT score (COPD assessment test), HADS (Hospital Anxiety and Depression Scale) depression score, HADS anxiety score, GSE (Generalized Self-Efficacy Scale) score, SF-12 PCS (Physical Component Scale), SF-12 MCS (Mental Component Scale) adjusted models: N: 164-171; Nagelkerke’s R2: .09–.16